Page last updated: 2024-08-18

pyrazolanthrone and olaparib

pyrazolanthrone has been researched along with olaparib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Chen, Y; Hou, X; Lin, X; Su, S; Tian, Y; Zhang, Q	1

Other Studies

1 other study(ies) available for pyrazolanthrone and olaparib

Article	Year
The Drug Combination of SB202190 and SP600125 Significantly Inhibit the Growth and Metastasis of Olaparib-resistant Ovarian Cancer Cell. Current pharmaceutical biotechnology, 2018, Volume: 19, Issue:6 Topics: Animals; Anthracenes; Autophagy; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Female; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phthalazines; Piperazines; Protein Kinase Inhibitors; Pyridines	2018

Article

Year

The Drug Combination of SB202190 and SP600125 Significantly Inhibit the Growth and Metastasis of Olaparib-resistant Ovarian Cancer Cell.

Current pharmaceutical biotechnology, 2018, Volume: 19, Issue:6

Topics: Animals; Anthracenes; Autophagy; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Female; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phthalazines; Piperazines; Protein Kinase Inhibitors; Pyridines

2018